C-Peptide of Insulin ELISA by Ansh Labs

Manufacturer Ansh Labs  |   Model: AL-151  |  Available Worldwide
Although the C-peptide of insulin is biologically inactive, it has a longer circulating half-life than insulin and undergoes relatively minimal hepatic metabolism. In addition, C-peptide of insulin assays may be analytically more sensitive than insulin assays. Because of these factors, measurement of C-peptide of insulin may be useful in evaluating insulin secretion in a variety of clinical conditions.  


C-Peptide of Insulin ELISA by Ansh Labs product image
C-Peptide of Insulin ELISA
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

The Ansh Labs’ Intact IGFBP-3 ELISA is a quantitative two-step sandwich type immunoassay. The immunoassay methods designed for the measurement of bioactive IGF-I, total and Intact IGFBP-3 in patient samples could be of practical value for the diagnosis or prediction of various pathologies including growth abnormalities and cancer. The Intact IGFBP-3 Assay uses an acidification and neutralization method to dissociate Intact IGFBP-3 from all the binding subunits. Intact IGFBP-3 levels are quantified in the extracted samples using a highly sensitive and specific Intact IGFBP-3 ELISA. Total IGFBP-3 levels can be measured using Total IGFBP-3 ELISA (AL-120).

  • Wide dynamic range of 3.5-117 ng/mL
  • Sensitive to 1.37 ng/mL
  • Total 1.5 hr incubation at RT
  • Long shelf life of 24 months

Research Use Only within the United States. Ansh Labs is an FDA registered manufacturer of diagnostic test kits, antibodies, antigens, and proteins.